Exposure to low intensity ultrasound removes paclitaxel cytotoxicity in breast and ovarian cancer cells

Exposure to low intensity ultrasound removes paclitaxel cytotoxicity in breast and ovarian cancer cells

Abstract Background Paclitaxel (Taxol) is a microtubule-stabilizing drug used to treat several solid tumors, including ovarian, breast, non-small cell lung, and pancreatic cancers. The current treatment of ovarian cancer is chemotherapy using paclitaxel in combination with carboplatin as a frontline...

Full description

Bibliographic Details
Main Authors: Celina Amaya, Shihua Luo, Julio Baigorri, Rogelio Baucells, Elizabeth R. Smith, Xiang-Xi Xu
Format: Article
Language:English
Published: BMC 2021-09-01
Series:BMC Cancer
Subjects:
Ultrasound wave
Microtubule
Taxol/paclitaxel
Cytotoxicity
Lysosomal degradation
Ovarian cancer
Online Access:https://doi.org/10.1186/s12885-021-08722-7

Internet

https://doi.org/10.1186/s12885-021-08722-7

Similar Items